Ronald W W Stam

11PUBLICATIONS
98CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

|Oct 08, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Louise Ahlgren, Mattias Pilheden, Helena Sturesson

|Jul 29, 2025
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Alastair L Smith, Nicholas Denny, Catherine Chahrour

|Jul 11, 2025
Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state.

Ariana S Calderón, Roshanak Ghazanfari, Zahra Masoumi

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

Pageof 2

Frequent Collaborators

3 joint publications

Pauline Schneider

3 joint publications

Narcís Fernandez-Fuentes

3 joint publications

Clara Bueno

3 joint publications

Meritxell Vinyoles